Mar 31, 2013

Altimmune Q1 2013 Earnings Report

Total Revenue
$6.48M
Previous year: $6.15M
+5.3%
EPS
-$1.33
Previous year: -$2
-33.3%
Cash and Equivalents
$12.9M
Previous year: $15.3M
-15.9%
Free Cash Flow
$235K
Total Assets
$22M
Previous year: $24.8M
-11.2%

Altimmune

Altimmune